Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 11:24 am Purchase | 2024-12-31 | 13G | INSPIREMD INC NSPR | Rosalind Advisors Inc. | 9,933,964 9.900% | 2,495,783 (+33.55%) | Filing History |
| 2025-02-04 3:35 pm Purchase | 2024-12-31 | 13G | MYOMO INC MYO | Rosalind Advisors Inc. | 7,574,330 9.900% | 2,998,945 (+65.55%) | Filing History |
| 2025-02-03 4:57 pm Purchase | 2024-12-31 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 249,092 9.900% | 16,744 (+7.21%) | Filing History |
| 2025-01-27 4:02 pm Purchase | 2024-12-23 | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 6,659,993 9.900% | 3,896,525 (+141.00%) | Filing History |
| 2024-12-02 11:53 am Unchanged | 2024-11-12 | 13D | NEURAXIS INC NRXS | Rosalind Advisors Inc. | 2,100,840 9.900% | 0 (Unchanged) | Filing History |
| 2024-12-02 09:57 am Purchase | 2024-11-12 | 13G | NEURAXIS INC NRXS | Rosalind Advisors Inc. | 2,100,840 9.900% | 2,100,840 (New Position) | Filing History |
| 2024-11-15 10:33 am Unchanged | 2024-10-30 | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-14 9:46 pm Unchanged | 2024-10-30 | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-06 10:48 am Sale | 2024-10-31 | 13G | BIOFRONTERA INC BFRI | Rosalind Advisors Inc. | 7,196,776 6.900% | -675,713 (-8.58%) | Filing History |
| 2024-10-28 4:02 pm Unchanged | 2024-09-30 | 13G | INSPIREMD INC NSPR | Rosalind Advisors Inc. | 7,438,181 9.800% | 0 (Unchanged) | Filing History |
| 2024-10-23 3:14 pm Unchanged | 2024-09-30 | 13G | BIOFRONTERA INC BFRI | Rosalind Advisors Inc. | 7,872,489 8.900% | 0 (Unchanged) | Filing History |
| 2024-10-23 3:05 pm Unchanged | 2024-09-30 | 13G | POLYPID LTD COM NO PAR PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 0 (Unchanged) | Filing History |
| 2024-10-23 2:57 pm Purchase | 2024-09-30 | 13G | MEDIWOUND LTD MDWD | Rosalind Advisors Inc. | 628,050 5.800% | 114,560 (+22.31%) | Filing History |
| 2024-10-23 2:44 pm Sale | 2024-09-30 | 13G | TREVI THERAPEUTICS INC TRVI | Rosalind Advisors Inc. | 750,000 1.030% | -641,577 (-46.10%) | Filing History |
| 2024-10-23 2:26 pm Sale | 2024-09-30 | 13G | SPRUCE BIOSCIENCES INC SPRB | Rosalind Advisors Inc. | 0 0.000% | -20,112 (Position Closed) | Filing History |
| 2024-10-18 2:52 pm Purchase | 2024-09-30 | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 552,500 5.500% | 49,357 (+9.81%) | Filing History |
| 2024-10-18 2:21 pm Unchanged | 2024-09-30 | 13G | MYOMO INC MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |
| 2024-08-14 7:20 pm Purchase | 2024-08-06 | 13G | POLYPID LTD COM NO PAR PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 270,372 (+65.02%) | Filing History |
| 2024-08-14 7:15 pm Purchase | 2024-07-25 | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 232,348 9.900% | 99,262 (+74.58%) | Filing History |
| 2024-07-12 10:35 am Unchanged | 2024-06-28 | 13G | MYOMO INC MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | Filing History |